Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
type: Generically Dependent Continuant
type: Information Content Entity
related by: 252876784
type: Thing
type: Document
most specific type: Academic Article
type: Article
related by: 252876788
related by: 252876791
type: Continuant
language: Inglese
type: Entity
related by: 252876789
related by: 252876786
type: Academic Article

Entity
type: Class

RDF description of Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL - http://irises.unisr.it/resource/item/159626
rights: termsOfUse
date: 2026-08-24T02:42:28
publisher: Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
type: Document

Generically Dependent Continuant
type: Class

Article
type: Class

Inglese
type: Language

Information Content Entity
type: Class

252876791
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

252876784
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

252876786
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

252876789
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL

252876788
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL